Stocks To Buy

When it comes to investing, it helps to be a straight shooter (and a bit of an optimist). But let’s call it for what it is: FAANG stocks, Facebook (NASDAQ:FB) included, have not been doing very well lately. In fact, FB stock stock is down about 12% from its high about a month ago. Source:

Out of 25 packaged food stocks with a market capitalization of more than $2 billion, Beyond Meat (NASDAQ:BYND) has the best performance in 2020, up 123% through Oct. 1 If you broaden the search to include all food-related companies — both consumer cyclical and consumer defensive — Beyond Meat still has the best performance year

By best estimates, we’re less than a month away from the launch date of the Apple (NASDAQ:AAPL) iPhone 12 — an event that will have a huge impact on AAPL stock. Source: ZorroGabriel / Shutterstock.com I recently shared with my readers why I think your best play for Apple may be after the iPhone reveal.

When things are this wild on Wall Street, I like to bet on champions. Advanced Micro Devices (NASDAQ:AMD) was the best performing stock in the entire S&P 500 for two years running. This year AMD stock is also doing well up 72%, which is more than double that of the NASDAQ and 30% more than

[embedded content] It’s been a rough year for Norwegian Cruise Line (NYSE:NCLH) and owners of NCLH stock. Source: Roberto Sorin / Shutterstock.com Coming into the year, the cruise industry was riding high on strong consumer spending and healthy travel appetite. NCLH was trading near all-time highs around $60. Revenues and profits were soaring. Life was

Biotechnology company Inovio Pharmeuticals (NASDAQ:INO) is known worldwide as an innovative developer of medical solutions based on DNA science. Of particular focus to INO stock investors is INO-4800, which is Inovio’s DNA-based vaccine candidate for Covid-19, the disease caused by the novel coronavirus. Source: Ascannio / Shutterstock.com Back in late July, Inovio made the headlines when

[embedded content] Source: Christopher Penler / Shutterstock.com Jumia (NYSE:JMIA) was once heralded as the Amazon (NASDAQ:AMZN) of Africa. That was back in April 2019, when JMIA stock popped from its $14.50 IPO price to a $50+ price tag in a matter of days. Since then, the hype has faded, mostly because — as it turns

Inovio (NASDAQ:INO) stock is up almost 21% in the last month, despite the biotech company becoming an afterthought in the race for a Covid-19 vaccine. Although it was one of the first companies to develop a SARS-Cov 2 vaccine candidate, INO stock could not sustain the momentum. Source: Ascannio / Shutterstock.com So, what’s driving the recent

While the S&P 500 and a wide range of stocks continue their September slide, many investors are understandably jittery, wondering if a second market crash is coming this year. In response, they’re searching for industries that can offer more stability, but also growth and income over the coming quarters. One such group are the so-called

Clinical-stage biopharmaceutical company Sorrento Therapeutics (NASDAQ:SRNE) has been in the financial press recently, and not necessarily in a good way. In fact, a U.S. Food and Drug Administration (FDA) ruling from August undoubtedly made some SRNE stock holders wriggle in their seats. Source: Shutterstock As it turned out, Sorrento had an unexpected competitor for its

To give you an idea of how vital women CEOs are to environmental, social and governance (ESG) investment strategies, former Bank of England and Bank of Canada governor Mark Carney was appointed in late August as Brookfield Asset Management’s (NYSE:BAM) head of ESG investing. What does this have to do with women as CEOs and

During times of uncertainty, investors crave a sure thing. There are times to be “risk-on” and there are times to be “risk-off.” When investors flock to the latter, they often look for companies with no debt. That doesn’t mean these stocks won’t fluctuate with the overall market. But there is a level of comfort in

[embedded content] In a sudden and sharp reversal that many were warning about for weeks, red-hot tech stocks fell off a cliff in September, with the tech-heavy Nasdaq index falling into correction territory over the course of roughly one week. Now where are all the good tech stocks to buy? While many out there are

Renewed interest in emerging biotechnology companies lifted Sorento Therapeutics (NASDAQ:SRNE) recently. Excessive bearish volumes against the stock could squeeze them out further. If Sorrento continues to post positive news in its drug and testing developments on the novel coronavirus, then SRNE stock may keep rising. Source: Shutterstock At a 34.3% short float, the bearish bet

[embedded content] Workhorse (NASDAQ:WKHS) has been absolutely on fire in 2020, with WKHS stock skyrocketing 825% higher this year on the back of abundant investor optimism with respect to the company’s ability to disrupt the last-mile delivery market with a next-gen electric delivery van. Source: Photo from WorkHorse.com This optimism is not misplaced. All transportation

California-based Alteryx (NYSE:AYX) is a leader in the field of data analytics. The company’s Alteryx Analytic Process Automation (APA) platform offers end-to-end automation of data analytics. This means faster results and the ability for employees who aren’t trained data scientists to leverage the technology. It’s used by over 6,000 customers globally. After reaching record highs

[embedded content] The likes of DraftKings (NASDAQ:DKNG), Virgin Galactic (NASDAQ:SPCE) and Nikola Motors (NASDAQ:NKLA) have had enormous success in using special purpose acquisition companies (or SPACs, for short) to go public in 2020. So it should be no surprise that companies of all sorts — such as Kensington Capital Acquisition (NYSE:SPAC) — are coming out

Mainland China and Hong Kong telecommunications services provider China Mobile (NYSE:CHL) isn’t heatedly discussed among financial-news pundits in America. You won’t hear much about CHL stock on U.S.-based message boards either. Source: testing / Shutterstock.com Thus, depending on your location, CHL stock might be flying almost entirely under the radar. Yet InvestorPlace contributor Faizan Farooque

Investors remain skeptical when it comes to cannabis stocks. And unsurprisingly, Canopy Growth (NYSE:CGC) hasn’t been immune. CGC stock has rallied from March lows, but it’s still down 25% year-to-date and near its lowest level in almost four months. Source: Shutterstock Let’s be honest: there are reasons for the trading frustration. The Canadian market in

Up 25% year to date, Microsoft (NASDAQ:MSFT) is a gift that keeps on giving this year. There are several hot reasons to invest in MSFT stock that have helped it succeed amid the novel coronavirus pandemic. But now one of those hot reasons — its prospects in gaming — is even hotter. Source: The Art

[embedded content] Chewy (NASDAQ:CHWY) stock has been on fire in 2020, at one point rising as much as 140% year-to-date on the back of abundant investor optimism that the company is the midst of pioneering a future wherein we buy all of our pet food and toys online. Source: designs by Jack / Shutterstock.com This

One of the trends the novel coronavirus has brought our lives is following what Robinhood investors buy. Whenever a news headline mentions a certain stock has become popular among retail investors using the online broker, there is typically renewed interest in that company. Therefore today, we will introduce three sports stocks Robinhood investors are buying, The